Bloomwell Group

What it is

Bloomwell Group is a German cannabis company headquartered in Frankfurt am Main. It operates as a holding structure for several medical-cannabis-focused businesses, the two most visible being Algea Care, a telemedicine platform that connects patients with physicians who can issue cannabis prescriptions, and Ilios Santé, an import and distribution brand supplying medical cannabis flower and extracts to German pharmacies ^[1][2].

The company was co-founded by Niklas Kouparanis and Julian Wichmann and began trading around 2020, positioning itself as a vertically oriented operator within Germany's medical cannabis framework rather than a cultivator or consumer-product brand ^[1][3].

Ownership and structure

Bloomwell Group is privately held. Public records and trade-press reporting describe it as a holding company with subsidiaries including Algea Care GmbH and Ilios Santé GmbH ^[1][2]. Niklas Kouparanis is generally identified in German and European cannabis trade press as CEO and a co-founder ^[3][4].

Because Bloomwell is not publicly listed, there is no audited annual report comparable to those of listed Canadian or US operators. Shareholder details, valuations, and funding rounds reported in the press (for example, a 2022 Series A round) come from company announcements and have not been independently verified in this article ^[3]. Weak / limited

Market and category focus

Bloomwell focuses on the German medical cannabis market, which expanded significantly after the April 2024 partial decriminalisation and rescheduling of cannabis under the Cannabisgesetz (CanG) and the Medizinal-Cannabisgesetz (MedCanG). Under the new framework, cannabis is no longer classified as a narcotic for medical purposes, lowering some barriers to prescription and telemedicine workflows ^[5][6].

The group's activities cluster around two main lines:

• Telehealth prescribing through Algea Care, which offers video consultations with licensed German physicians for patients seeking medical cannabis treatment.
• Import and wholesale supply through Ilios Santé, which brings cannabis flower and extracts into Germany for dispensing through pharmacies.

Bloomwell does not operate recreational retail; Germany's adult-use framework as of 2024 does not include commercial dispensaries, only non-commercial cultivation associations (Anbauvereinigungen) ^[5].

Notable products and services

This section describes services that have been publicly reported; inclusion is not a recommendation.

• Algea Care: A telemedicine service through which patients can book video appointments with cooperating physicians. If a physician determines medical cannabis is appropriate, a prescription is issued and can be filled at partner or patient-chosen pharmacies ^[2][4].
• Ilios Santé: An import brand listed in trade press as a supplier of medical cannabis products to German pharmacies. Specific cultivar lineups change over time and should be checked directly with pharmacies or the company ^[2].

Weedpedia does not endorse any specific telehealth provider, prescriber, or cannabis product. Suitability of medical cannabis is a clinical question for a qualified physician.

Reputation, awards, and controversies

Bloomwell and Algea Care are frequently cited in European cannabis trade media (e.g., Business of Cannabis, MJBizDaily, Krautinvest) as among the more prominent German medical cannabis operators by patient volume, though independent figures are scarce ^[3][4]. Weak / limited

Telemedicine-led cannabis prescribing in Germany has attracted broader criticism from some medical associations and politicians who argue that short video consultations may not provide adequate clinical assessment for chronic-pain or psychiatric indications. These concerns apply to the telemedicine prescribing model in general, not to Bloomwell specifically, but they are part of the regulatory backdrop the company operates in ^[6][7]. Disputed

As of the last check date, we are not aware of publicly documented regulatory sanctions against Bloomwell Group, Algea Care, or Ilios Santé. Absence of reported sanctions is not the same as a clean record; check the relevant Landesbehörden (state authorities) and BfArM for the most current status.

Availability and legal-market notes

Bloomwell's services are offered within Germany under the country's medical cannabis framework. Algea Care consultations are restricted to people who can lawfully receive medical care in Germany, and prescriptions must be filled at licensed German pharmacies ^[2][5].

Medical cannabis in Germany is dispensed by prescription only; it is not sold over the counter, and importing cannabis products from a German pharmacy into another country is generally illegal without specific permits ^[5][6].

What to verify before relying on brand claims

If you are considering using Bloomwell-affiliated services or products, independently confirm:

1. Prescriber credentials. Check that the physician you see is registered with the relevant German Ärztekammer (medical chamber).
2. Pharmacy legitimacy. Confirm that any dispensing pharmacy is licensed in Germany; the Bundesvereinigung Deutscher Apothekerverbände (ABDA) and state pharmacy chambers maintain registries.
3. Product details. Cultivar names, THC/CBD content, and country of origin should appear on the pharmacy label; cross-check against the importer's published product list.
4. Insurance coverage. Statutory health insurance (GKV) coverage of medical cannabis requires a separate approval process and is not guaranteed by any clinic or telehealth provider ^[6].
5. Current regulatory status. German cannabis law is changing quickly; rules in force at the time of treatment may differ from those described in marketing material.

Profile last checked: 2024.

Sources

How this page was made